| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
73 |
| Employees |
64 |
| Revenues (TTM) (Millions $) |
12 |
| Net Income (TTM) (Millions $) |
-53 |
| Cash Flow (TTM) (Millions $) |
-17 |
| Capital Exp. (TTM) (Millions $) |
4 |
Gelesis Holdings Inc
Gelesis Holdings Inc is a biotechnology company focused on developing and commercializing treatments for obesity and gastrointestinal disorders. The company's flagship product, Plenity, is an oral, non-systemic capsule designed to induce a feeling of fullness and promote weight loss. Plenity is made up of naturally derived materials that expand in the stomach to help control appetite and reduce calorie intake. Gelesis Holdings Inc is committed to providing innovative and effective solutions for the management of obesity and related health conditions.
Company Address: 501 Boylston Street Boston 2116 MA
Company Phone Number: 456-4718 Stock Exchange / Ticker: GLS
|
%
0.25%